Upload
merilyn-eileen-lucas
View
216
Download
0
Embed Size (px)
DESCRIPTION
The 6 th National Scientific Conference on HIV/AIDS Comprehensive care 1.Combination of –Medical + psychosocial interventions –Harm reduction interventions 2.Multidisciplinary, integrated and long-term approach (guidelines for the treatment of drug dependence: a European perspective, EMCDDA, 2011) –Relapse belongs to the recovery process 3.Gold standard for opioid dependence –Opioid agonist treatment + psychosocial intervention
Citation preview
THE 6TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS
State of the art and new perspectives in drug addiction
treatmentDr L Michel, MD, PhD
Inserm U1178
Centre Pierre Nicole/French Red Cross
Paris
The 6th National Scientific Conference on HIV/AIDS
Drug dependence
1. Addiction is a disease
2. Addiction is a brain disease, but not only
– Genetic, environmental and social factors…
– Psychological factors
3. Addiction is a chronicle disease
4. Addiction is treatable
The 6th National Scientific Conference on HIV/AIDS
Comprehensive care 1. Combination of
– Medical + psychosocial interventions
– Harm reduction interventions
2. Multidisciplinary, integrated and long-term approach (guidelines for the treatment of drug dependence: a European perspective, EMCDDA, 2011)
– Relapse belongs to the recovery process
3. Gold standard for opioid dependence
– Opioid agonist treatment + psychosocial intervention
The 6th National Scientific Conference on HIV/AIDS
Abstinence rates are higher in patients receiving psychosocial interventions
Psychosocial interventions: cognitive and behavioural approaches contingency management Techniques (WHO, 2009)
The 6th National Scientific Conference on HIV/AIDS
Reach all populations
• Enlarge treatment options
– Improve existing options
• Methadone induction in primary care in France (ANRS-Methaville)
• 6 months buprenorphine implants (Rosenthal, 2013)
• Naltrexone implants (3-6 months): – «Better designed research is needed to establish the safety and efficacy of
naltrexone implants. Until such time, their use should be limited to clinical trials » (Larney, 2014)
The 6th National Scientific Conference on HIV/AIDS
Reach all populations
• Enlarge treatment options
– Create new options
• Oral 24h morphine release: Austria, Switzerland, Slovenia, and UK soon
• Diacetylmorphine: Switzerland, Neederland, Denmark for injecting drug users
• Injectable buprenorphine (Bup IV trial, France)
The 6th National Scientific Conference on HIV/AIDS
Improve damages prevention
7Curr Opin HIV AIDS 2012, 7:362–368
The 6th National Scientific Conference on HIV/AIDS
Improve damages prevention• Medication assisted treatment
– Opioid agonist treatments efficient to prevent HIV & HCV (Tsui, 2014 ; Nolan, 2014)
– Preventive impact enhanced if strategies combined
• Substance-use treatment + support for safe injection more effective at reducing HCV seroconversion (Hagan, 2011)
– Van den Berg (2007): Full participation in harm reduction programmes including NEP + OST at adequate dosage (≥ 60mg methadone/day)
The 6th National Scientific Conference on HIV/AIDS
Improve damages prevention• Needle and syringes programs
– ANRS-AERLI program (France): educational intervention on risks associated with drug injection (Roux, 2015)
• HCV transmission related to
– Sharing paraphernalia (Pouget 2012)
– Pipe and straw sharing (Jauffret 2009, Aaron 2008)
– Supervised consumption rooms: prevent individual and social damages related to drug use practices (Potier, 2014)
• To be opened in 2016 in Paris, Strasbourg, Bordeaux ?
The 6th National Scientific Conference on HIV/AIDS
Improve damages prevention
• Decrease mortality related to overdoses
– Spread of nasal naloxone among DUs (January 2016)
• Reach High risk populations
– Prison setting: reach a principle of equivalence for harm reduction measures (ANRS-Pride program)
The 6th National Scientific Conference on HIV/AIDS
Stimulant use and dependence
• No agonist treatment
• Main treatment modality: psychosocial interventions
– cognitive-behavioural therapy
– contingency management
• Research
– Trials with methylphenidate, naltrexone, antipsychotics, dexamphetamine, butyrylcholinesterase (cocaine metabolism), anti-cocaine vaccine, varenicline
The 6th National Scientific Conference on HIV/AIDS
Prevent !
•Delaying drug use onset
– Every year use of a substance is delayed, the risk of developing a substance use disorder is reduced
•Use specific tools for teenagers prevention
– Working on emotions rather than drugs dissuasion
•Use specific therapy for young drug users
– Multidimensional family therapy
The 6th National Scientific Conference on HIV/AIDS
Perspectives
• Future:
– Interventions on the reward circuitry ?
• UNGASS 2016:
– Special Session of the United Nations General Assembly on the World Drug Problem
• Ending the drug war ?